AIC
ACAD icon

AWM Investment Company’s Acadia Pharmaceuticals ACAD Stock Holding History

AWM Investment Company’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-50,000
Closed -$1.78M – 94
2015
Q4 		$1.78M Hold
50,000
– – 0.35% 61
2015
Q3 		$1.65M Hold
50,000
– – 0.32% 74
2015
Q2 		$2.09M Hold
50,000
– – 0.3% 82
2015
Q1 		$1.63M Sell
50,000
-16,357
-25% -$562K 0.23% 91
2014
Q4 		$2.11M Buy
+66,357
New +$1.88M 0.29% 84

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

AWM Investment Company's ACAD Position: Q1 2016 in Review

AWM Investment Company sold out of Acadia Pharmaceuticals (ACAD) in Q1 2016, closing a stake of 50,000 shares — an estimated $1.78M sold.

AWM Investment Company first reported a position in ACAD in Q4 2014 and held it in 5 quarters. The position peaked at $2.11M in Q4 2014. 213 funds tracked by Wall St. Rank hold ACAD as of Q1 2016.

  • AWM Investment Company reported no remaining Acadia Pharmaceuticals position as of Q1 2016 after selling out during the quarter.
  • AWM Investment Company sold 50,000 Acadia Pharmaceuticals shares in Q1 2016, an estimated $1.78M.
  • AWM Investment Company first reported a position in Acadia Pharmaceuticals in Q4 2014 and held it in 5 quarters.
  • AWM Investment Company's Acadia Pharmaceuticals position peaked at $2.11M in Q4 2014.
  • 213 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q1 2016.

Based on AWM Investment Company's 13F filing for Q1 2016, filed 5 May 2016.